2,6-Dichloro-4-methylnicotinonitrile
2,6-Dichloro-4-methylnicotinonitrile Basic information
- Product Name:
- 2,6-Dichloro-4-methylnicotinonitrile
- Synonyms:
-
- BUTTPARK 43\57-14
- IFLAB-BB F0907-8363
- 3-PYRIDINECARBONITRILE, 2,6-DICHLORO-4-METHYL-
- 3-CYANO-2,6-DICHLORO-4-METHYLPYRIDINE
- 3-Cyano-4-methyl-2,6-dichloropyridine
- 2,6-DICHLORO-4-METHYL-3-CYANOPYRIDINE
- 2,6-DICHLORO-4-METHYLNICOTINONITRILE
- 2,6-DICHLORO-4-METHYLPYRIDINE-3-CARBONITRILE
- CAS:
- 875-35-4
- MF:
- C7H4Cl2N2
- MW:
- 187.03
- EINECS:
- 212-873-7
- Product Categories:
-
- Building Blocks
- C7 to C18
- C7 to C8
- Chemical Synthesis
- Halogenated Heterocycles
- Heterocyclic Building Blocks
- Pyridine series
- C7 and C8Heterocyclic Building Blocks
- Halogenated Heterocycles
- Heterocyclic Building Blocks
- API intermediates
- Pyridines
- Chloropyridines
- Halopyridines
- bc0001
- Mol File:
- 875-35-4.mol
2,6-Dichloro-4-methylnicotinonitrile Chemical Properties
- Melting point:
- 108-112 °C(lit.)
- Boiling point:
- 118 °C / 5mmHg
- Density
- 1.42±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,2-8°C
- solubility
- 0.4g/l
- pka
- -4.53±0.10(Predicted)
- form
- solid
- PH
- 3.5 (H2O, 20℃)(aqueous suspension)
- Appearance
- White to light brown Solid
- InChI
- InChI=1S/C7H4Cl2N2/c1-4-2-6(8)11-7(9)5(4)3-10/h2H,1H3
- InChIKey
- LSPMHHJCDSFAAY-UHFFFAOYSA-N
- SMILES
- C1(Cl)=NC(Cl)=CC(C)=C1C#N
- CAS DataBase Reference
- 875-35-4(CAS DataBase Reference)
Safety Information
- Hazard Codes
- T,Xi
- Risk Statements
- 20/21-25-37/38-41-43-36/37/38
- Safety Statements
- 26-36/37/39-45-36
- RIDADR
- UN 2811 6.1/PG 3
- WGK Germany
- 3
- Hazard Note
- Irritant
- HazardClass
- 6.1
- PackingGroup
- III
- HS Code
- 29333990
MSDS
- Language:English Provider:SigmaAldrich
- Language:English Provider:ALFA
2,6-Dichloro-4-methylnicotinonitrile Usage And Synthesis
Chemical Properties
White to light brown powder
Uses
2,6-Dichloro-4-methylnicotinonitrile is a pharmaceutical intermediate compound of Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of human immunodeficiency virus (HIV).
Synthesis
5444-02-0
875-35-4
General procedure for the synthesis of 3-cyano-4-methyl-2,6-dichloropyridine from 6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile: 6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (28.0 g, 195.2 mmol) was dissolved in phosphorus triclosan (60.0 mL). The reaction mixture was transferred to a pressure tube, sealed and heated to 180 °C for 6 hours. Upon completion of the reaction, it was cooled to room temperature and excess phosphorous trichloride was removed by distillation under reduced pressure. Crushed ice was slowly added to the residue and a solid was precipitated. The solid was collected by filtration and dried under vacuum to afford the target product 3-cyano-4-methyl-2,6-dichloropyridine in 92% yield without further purification.
References
[1] Journal of Heterocyclic Chemistry, 1995, vol. 32, # 3, p. 979 - 984
[2] Patent: WO2014/165232, 2014, A1. Location in patent: Paragraph 0174; 0175
[3] Patent: US2015/119387, 2015, A1. Location in patent: Paragraph 0175; 0176
[4] Patent: JP2017/95498, 2017, A. Location in patent: Paragraph 0079; 0080
[5] Patent: CN104530042, 2017, B. Location in patent: Paragraph 0171; 0177; 0178; 0179
2,6-Dichloro-4-methylnicotinonitrileSupplier
- Tel
- 18306022109
- 3236923470@qq.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 4006356688 18621169109
- market03@meryer.com
- Tel
- 400-0066400 13621662912
- sales@jonln.com
- Tel
- 400-6106006
- saleschina@alfa-asia.com
2,6-Dichloro-4-methylnicotinonitrile(875-35-4)Related Product Information
- Basic Violet 1
- 2-Chloro-5-chloromethylpyridine
- 2,6-Dichloropyridine
- Methyl acrylate
- Methyl salicylate
- Methanol
- Tribenuron methyl
- 4-Methylpyridine
- 3-Cyanopyridine
- 2,6-Lutidine
- Clopyralid
- 3-Cyano-4-methylpyridine
- Methylparaben
- Kresoxim-methyl
- Methyl
- 2-Chloro-3-picoline
- 2-Chloro-5-methylpyridine
- 2-Chloro-4-picoline